Perrigo reports a 54% fall in profit

The company which bought Irish drug firm, Elan last year has reported a near 54% fall in annual net profit.

Perrigo reports a 54% fall in profit

New York-listed and Dublin-domiciled Perrigo — which is ranked as the leading maker of generic over-the-counter drugs in the US — yesterday reported full-year net income of $205.3m (€154m) for the 12 months to the end of June. This was down by nearly 54% on the $442m (€330m) profit reported the previous year.

Net sales for the year were up from $3.54bn to just under $4.1bn and the company saw strong double-digit growth — across both reported net income and net sales — in the fourth quarter; buoyed by new product sales of $65m and $112m in sales attributable to the Elan takeover, specifically sales and royalties from the latter’s MS treatment, Tysabri.

Perrigo’s management is guiding 13%-17% growth in adjusted earnings per share for its new financial year.

Chief executive Joe Papa said the Elan buy has transformed the firm into a truly global organisation, which is “uniquely positioned” to continue its growth.

Earlier this year, Perrigo said it incurred once-off costs of over €200m from its $9.5bn purchase of Elan, which was completed at the end of last year. Overall, however, Perrigo expects to benefit from around $150m in annual tax savings from acquiring Elan and moving its tax base to Ireland.

More in this section

IE logo
Devices


UNLIMITED ACCESS TO THE IRISH EXAMINER FOR TEAMS AND ORGANISATIONS
FIND OUT MORE

The Business Hub
Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Sign up
Puzzles logo
IE-logo

Puzzles hub

Visit our brain gym where you will find simple and cryptic crosswords, sudoku puzzles and much more. Updated at midnight every day. PS ... We would love to hear your feedback on the section right HERE.

Lunchtime
News Wrap

A lunchtime summary of content highlights on the Irish Examiner website. Delivered at 1pm each day.

Sign up
Revoiced
Newsletter

Some of the best bits from irishexaminer.com direct to your inbox every Monday.

Sign up